Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 1 |
Descriptor
Attention Deficit Disorders | 1 |
Behavior Problems | 1 |
Body Weight | 1 |
Drug Therapy | 1 |
Eating Disorders | 1 |
Emotional Response | 1 |
Hyperactivity | 1 |
Maintenance | 1 |
Pharmacology | 1 |
Preschool Children | 1 |
Safety | 1 |
More ▼ |
Source
Journal of the American… | 1 |
Author
Abikoff, Howard | 1 |
Chuang, Shirley | 1 |
Davies, Mark | 1 |
Ghuman, Jaswinder | 1 |
Greenhill, Laurence | 1 |
Kollins, Scott | 1 |
McCracken, James | 1 |
McGough, James | 1 |
Posner, Kelly | 1 |
Riddle, Mark | 1 |
Skrobala, Anne | 1 |
More ▼ |
Publication Type
Journal Articles | 1 |
Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Wigal, Tim; Greenhill, Laurence; Chuang, Shirley; McGough, James; Vitiello, Benedetto; Skrobala, Anne; Swanson, James; Wigal, Sharon; Abikoff, Howard; Kollins, Scott; McCracken, James; Riddle, Mark; Posner, Kelly; Ghuman, Jaswinder; Davies, Mark; Thorp, Ben; Stehli, Annamarie – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To report on the safety and tolerability of methylphenidate (MPH) 3- to 5-year-old children with attention-deficit/hyperactivity disorder (ADHD) during 1 year of treatment. Method: Exactly 183 children (3-5 years old) entered a treatment study of MPH, consisting of a 1-week open-label lead-in (n = 183); a 5-week placebo-controlled,…
Descriptors: Safety, Maintenance, Preschool Children, Hyperactivity